Julen
Oyarzabal Santamarina
Investigador hasta 2018
University College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de University College London (6)
2024
2021
-
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Gut, Vol. 70, Núm. 2, pp. 388-400
2020
-
Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis
Cancers, Vol. 12, Núm. 12, pp. 1-27
2019
-
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Hepatology, Vol. 69, Núm. 2, pp. 587-603
2015
-
The CHEMDNER corpus of chemicals and drugs and its annotation principles
Journal of Cheminformatics, Vol. 7